首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

亞太地區 ELISA 診斷測試市場預測至 2030 年 - 區域分析 - 按採用、測試類型、應用程式和最終用戶

市場調查報告書

商品編碼

1494320

亞太地區 ELISA 診斷測試市場預測至 2030 年 - 區域分析 - 按採用、測試類型、應用程式和最終用戶

Asia Pacific ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 111 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太地區ELISA診斷測試市值為2.557億美元，預計2030年將達到5.0308億美元；預計2022年至2030年複合年成長率為8.8%。

創新產品推出支撐亞太 ELISA 診斷測試市場

ELISA 因其靈活性、靈敏度和易於使用等多種優點而成為最受歡迎的免疫分析測試之一。此外，ELISA 檢測試劑盒的低成本以及與高通量檢測相關的多方面適用性使其成為滿足各種研究和 IVD 要求的理想解決方案。憑藉低成本的適用性，檢測試劑盒的產品創新增強了對人類和動物研究的需求。此外，製造商也專注於利用內部設施開發 ELISA 檢測試劑盒。 Innovative Research 公司銷售多種 ELISA 試劑盒，可選擇性地辨識多種凝血劑、物種和抗體。「Human Factor IX Kit」就是 Innovative Research 生產的一個這樣的例子。人類凝血因子 IX 抗原測定旨在定量測定人類血漿中總因子 IX 抗原。此試劑盒建議僅用於研究目的，試劑最多可用於 96 項臨床測試。此外，在 COVID-19 大流行期間，製造商推出了 ELISA 測試的創新產品，加速了 ELISA 測試在人類中的採用。 2022 年 12 月，Pictor Limited 宣布推出「PictArray SARS-CoV-2 抗體測試」新產品，該產品已展示了針對患者和醫生的真正臨床實用性。新產品可檢測與 COVID-19 病毒相關的感染，產生的臨床結果可幫助患者和醫生治療和管理 SARS-CoV-2 感染。製造商推出的創新 ELISA 檢測試劑盒有望以低成本和多方面的應用為診斷與不同類型物種相關的各種感染提供有效的臨床結果。因此，從長遠來看，創新產品的推出將為製造商提供利潤豐厚的機會。

亞太地區 ELISA 診斷測試市場概覽

中國擁有強大而有彈性的公共衛生系統，能夠在傳染病威脅成為流行病之前迅速預防、發現和應對。中國的生態環境帶來了新出現、重新出現和新型疾病的風險，這些疾病可能威脅到中國和世界其他地區，因為中國擁有約 14 億的龐大人口和占世界 50% 的牲畜。《全球健康雜誌》2023年9月發表的一篇文章對中國東南部江蘇省法定傳染病的年發病率和死亡率進行了研究。研究得出的結論是，公共衛生政策在研究期間有效降低了腸道疾病、媒介傳播疾病和人畜共患疾病的發病率以及相關的死亡率，但性傳染病和血液傳播疾病（主要是梅毒和愛滋病）的發生率，增加了。

此外，世界各地不斷成長的航空旅行網路極大地增加了感染快速傳播的風險，包括可能導致流行病的感染，例如 COVID-19 大流行，從而導致全球貿易中斷、病例增加或死亡人數增加。該國預計將為參與該國 ELISA 診斷測試市場的本地和國際參與者提供利潤豐厚的機會。

亞太地區 ELISA 診斷測試市場收入及 2030 年預測（百萬美元）

亞太地區 ELISA 診斷測試市場細分

亞太地區 ELISA 診斷測試市場根據採用情況、測試類型、應用程式、最終用戶和國家進行細分。根據採用情況，亞太地區 ELISA 診斷測試市場分為人類和獸醫市場。 2022 年，人類細分市場將佔據更大的市場佔有率。

就測試類型而言，亞太地區ELISA診斷測試市場分為夾心ELISA、間接ELISA、競爭性ELISA以及多重攜帶式ELISA。 2022 年，間接 ELISA 細分市場佔據最大的市場佔有率。

根據應用，亞太地區 ELISA 診斷測試市場分為自體免疫疾病、傳染病、癌症診斷、蛋白質定量等。 2022 年，傳染病領域佔據最大的市場佔有率。

按最終用戶分類，亞太地區 ELISA 診斷測試市場分為醫院和診斷中心、製藥和生物技術公司、獸醫醫院和診斷實驗室等。 2022 年，醫院和診斷中心細分市場佔據最大的市場佔有率。

按國家/地區分類，亞太地區 ELISA 診斷測試市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國在亞太地區ELISA診斷檢測市場佔有率中佔據主導地位。

Bio-Rad Laboratories Inc.、Idex Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Pictor Ltd.、DiaSorin SpA、Elabscience Biotechnology Inc. 與 Bio-Techne Corp是亞太ELISA 診斷測試市場上的一些領先公司。

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities. Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests. Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans. In December 2022, Pictor Limited announced a new product launch of the "PictArray SARS-CoV-2 Antibody Test," which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Asia Pacific ELISA Diagnostics Tests Market Overview

China has a strong and resilient public health system that can rapidly prevent, detect, and respond to infectious disease threats before they become epidemics. China's ecology poses a risk for emerging, re-emerging, and novel diseases that could threaten China and the Rest of world owing to the vast population of ~ 1.4 billion and 50% of the world's livestock. In an article published by Journal of Global Health in September 2023, a study was carried out on annual incidence and fatality rates of notifiable infectious diseases in Jiangsu province of southeast China. The study concluded that public health policies have been effective in reducing the incidence of intestinal, vector-borne, and zoonotic diseases during the study period and the associated fatality, but that the incidence of sexually transmitted and blood-borne diseases, mainly syphilis and AIDS, has increased.

Additionally, growing network of air travel routes across the world dramatically increases the risk of rapid infection spread, including infections that may lead to pandemics, such as the COVID-19 pandemic, that result in disruption of global trade, rise in illness cases, or increase in deaths. The country is expected to provide lucrative opportunities to local and international players involved in ELISA diagnostics test market in the country.

Asia Pacific ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific ELISA Diagnostics Tests Market Segmentation

The Asia Pacific ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Asia Pacific ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Asia Pacific ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Asia Pacific ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Asia Pacific ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Asia Pacific ELISA diagnostics tests market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Asia Pacific ELISA diagnostics tests market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
- 1.2.1 Asia Pacific ELISA Diagnostic Tests Market - by Adoption
- 1.2.2 Asia Pacific ELISA Diagnostic Tests Market - by Test Type
- 1.2.3 Asia Pacific ELISA Diagnostic Tests Market - by Application
- 1.2.4 Asia Pacific ELISA Diagnostic Tests Market - by End User
- 1.2.5 Asia Pacific ELISA Diagnostic Tests Market - by Country

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific ELISA Diagnostic Test Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Infectious Diseases Among Animals
- 4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
- 4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
- 4.3.1 Innovative Product Launches
4.4 Future Trends
- 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - Asia Pacific Market Analysis

5.1 Overview
5.2 Asia Pacific ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

6.1 Overview
6.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
- 6.3.1 Overview
- 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
- 6.4.1 Overview
- 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

7.1 Overview
7.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
- 7.3.1 Overview
- 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
- 7.4.1 Overview
- 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
- 7.5.1 Overview
- 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
- 7.6.1 Overview
- 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
- 8.3.1 Overview
- 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
- 8.4.1 Overview
- 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
- 8.5.1 Overview
- 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
- 8.6.1 Overview
- 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Asia Pacific: ELISA Diagnostic Tests Market
- 10.1.1 Asia Pacific: ELISA Diagnostic Tests Market, by Country
  - 10.1.1.1 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
    - 10.1.1.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.5 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Bio-Rad Laboratories Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Idexx Laboratories Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Danaher Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pictor Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 DiaSorin SpA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Elabscience Biotechnology Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Financial Overview
- 12.9.4 SWOT Analysis
- 12.9.5 Key Developments
12.10 Bio-Techne Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. China ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 4. China ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. China ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. China ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. India ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 12. India ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. India ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 14. India ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 22. South Korea ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Asia Pacific ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 29. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
Figure 5. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. Asia Pacific: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 26. China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in ELISA diagnostics test Market